Alan Cheng, MD, FACS-Stanford Medicine Children's Health

Dr. Chang's clinical practice is based at the Lucile Packard Children's Hospital, and is focused on Pediatric Otology. He has specific clinical interests in congenital hearing loss, congenital ear anomalies, pediatric cochlear implantation, microtia and atresia reconstruction, and bone conduction implants. His research interests are also in hearing loss, and include neonatal hearing screening, genetics of hearing loss, otoacoustic emissions, auditory physiology, and ototoxicity. He developed the Chang and SIOP Ototoxicity Grading Scales, and is actively involved in several human clinical trials looking at the prevention of cisplatin ototoxicity that may drastically decrease the number of children developing hearing loss after chemotherapy.

Located in Palo Alto, CA, John Shinn MD is a renowned medical practice known for its exceptional patient care and innovative research initiatives. With a strong emphasis on advancing medical knowledge, this institution offers a wide range of specialized services, including cancer treatment, cardiovascular care, neurology, orthopedics, and organ transplants. Patients benefit from the expertise of a dedicated team of healthcare professionals who work together to provide comprehensive and personalized medical solutions. John Shinn MD's commitment to excellence is evident in its state-of-the-art clinical facilities, outpatient centers, and specialized programs. By fostering a collaborative environment that brings together physicians, nurses, researchers, and specialists, this institution strives to deliver top-tier medical care that supports patient well-being and pushes the boundaries of clinical practice. With a focus on continual improvement and patient-centered care, John Shinn MD stands as a beacon of medical excellence in the heart of Palo Alto. Generated using this brand's available information